| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/25/2004 | WO2003075741A9 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 03/25/2004 | WO2003072528A3 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 03/25/2004 | WO2003072060A3 Polypeptide formulation |
| 03/25/2004 | WO2003043613A3 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/25/2004 | WO2003040296A3 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 03/25/2004 | WO2003040134A9 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 03/25/2004 | WO2003031475A3 Antibodies against kdr, their production and uses |
| 03/25/2004 | WO2003014731B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 03/25/2004 | WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer |
| 03/25/2004 | WO2002102399A3 Mucosal repair by tff2 peptides |
| 03/25/2004 | WO2002072832A3 Therapeutic binding molecules |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002044342A3 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 03/25/2004 | WO2002002095B1 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
| 03/25/2004 | US20040059144 Aspirin-triggered lipid mediators |
| 03/25/2004 | US20040059136 7-carboxy-flavone derivatives preparation method and therapeutic use |
| 03/25/2004 | US20040059130 Benz(f)indole compounds useful for Inflammatory Diseases |
| 03/25/2004 | US20040059113 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 03/25/2004 | US20040059110 Such as N,N'-bis(2-hydroxybenzyl)-L-cystine |
| 03/25/2004 | US20040059004 10-aryl-11h-benzo[b]fluorene derivatives and analogs for medicinal use |
| 03/25/2004 | US20040058995 Agent for improving bone metabolism |
| 03/25/2004 | US20040058980 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 03/25/2004 | US20040058972 Therapy for neovascularization; antitumor agents; vision defects; antidiabetic agents; antiarthritic agents |
| 03/25/2004 | US20040058969 React with tubulin; forming microtubes; stabilization; antitumor, anticancer agents; antiinflammatory agnets; psoriasis; antiarthritic agents |
| 03/25/2004 | US20040058968 Antiinflammatory agents; autoimmune diseases; antiarthritic agents |
| 03/25/2004 | US20040058965 Alkanoic acid derivatives process for their production and use thereof |
| 03/25/2004 | US20040058964 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 03/25/2004 | US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058923 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 03/25/2004 | US20040058922 Tyrosine inhibitor; immunosuppressants; antiarthritic agents; autoimmune diseases; antiproliferative agent |
| 03/25/2004 | US20040058920 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 03/25/2004 | US20040058916 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 03/25/2004 | US20040058915 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/25/2004 | US20040058914 Combination drugs |
| 03/25/2004 | US20040058850 Using caspase inhibitor; antiinflammatory agents |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | US20040058448 Transgenic gram negative bacteria for production of oligo and/or polysaccharides; gene therapy and vaccine development |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058321 Comprises nucleotide sequences coding transforming growth factor binding proteins for diagnosis and treatment of osteoporosis and osteopenia |
| 03/25/2004 | US20040057992 6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol (laxofoxifene); a prodrug with a glidant, disintegrant, lubricant and diluent/filler in given amounts; unit dosage forms, including low dosage forms |
| 03/25/2004 | US20040057953 Modified peptides as therapeutic agents |
| 03/25/2004 | US20040057943 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 03/25/2004 | CA2502583A1 Isoquinoline derivatives having kinase inhibitory activity and medicament containing the same |
| 03/25/2004 | CA2498308A1 Parathyroid hormone-like polypeptides |
| 03/25/2004 | CA2498045A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 03/25/2004 | CA2497067A1 Amino-propanol derivatives |
| 03/24/2004 | EP1400810A2 Estrogen receptors and bone disease |
| 03/24/2004 | EP1400513A1 Unsymmetrical cyclic diamine compound |
| 03/24/2004 | EP1400252A1 Methods and compositions for healing and repair of articular cartilage |
| 03/24/2004 | EP1399570A2 Peptides for use as translocation factors |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399548A2 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 03/24/2004 | EP1399482A2 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 03/24/2004 | EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/24/2004 | EP1399440A1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors |
| 03/24/2004 | EP1399439A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 03/24/2004 | EP1399435A2 Pyridine derivatives useful as cd40:cd154 binding interruptors and use thereof to treat immunological complications |
| 03/24/2004 | EP1399433A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399420A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399406A2 Novel estrogen receptor ligands and methods i |
| 03/24/2004 | EP1399177A1 Bmp binding proteins for use in bone or cartilage regeneration |
| 03/24/2004 | EP1399175A2 Therapeutic use of rank antagonists |
| 03/24/2004 | EP1399165A2 Stabilized dispersion of phytosterol in oil |
| 03/24/2004 | EP1399162A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 03/24/2004 | EP1399155A2 Small molecules useful in the treatment of inflammatory disease |
| 03/24/2004 | EP1399151A2 A method for treating inflammatory diseases by administering a ppar-delta agonist |
| 03/24/2004 | EP1399146A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/24/2004 | EP1399137A1 Sulfonamides |
| 03/24/2004 | EP1399023A2 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
| 03/24/2004 | EP1349558A4 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 03/24/2004 | EP1303517B1 Indoloquinazolinones |
| 03/24/2004 | EP1252164B1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 03/24/2004 | EP1200399B1 Vitamin d3 analogs |
| 03/24/2004 | EP1196416B1 Substituted purine derivatives as inhibitors of cell adhesion |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | EP1143964B1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission |
| 03/24/2004 | EP1140895B1 Thiopyran compounds as inhibitors of mmp |
| 03/24/2004 | EP1124847B1 Lhrh analogues for the treatment of osteoporosis |
| 03/24/2004 | EP1124809B1 Benzoylpyridazines |
| 03/24/2004 | EP0912543B1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-[4- 2-(pyrrolidin-1-yl)ethoxy]phenyl chromane, hydrogen fumarate |
| 03/24/2004 | CN1484652A Antibodies to human IL-1 beta |
| 03/24/2004 | CN1484651A Production of recombinant BMP-2 |
| 03/24/2004 | CN1484644A Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/24/2004 | CN1484529A Gusuibu extracts for trvating osteoporosis and method for extracting same |
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
| 03/24/2004 | CN1483716A Stibene derivative organic amine salt, its preparation method, use and medicinal composition |
| 03/24/2004 | CN1483456A External used medicine for treating traumatic injury |
| 03/24/2004 | CN1483455A Jiegudan medicine for rejoining bone |
| 03/24/2004 | CN1483452A Compound traditional Chinese and western medicine for treating rheumatism and osteoarthritis and productive method thereof |
| 03/24/2004 | CN1483448A Traditional Chinese medicine for treating femoral head necrosis |
| 03/24/2004 | CN1483436A Medicinal composition for treating bone fracture |
| 03/24/2004 | CN1483432A Clathrate compound of daemonorops draco |
| 03/24/2004 | CN1483426A Medicine for treating cervical spondylopathy and preparation precess thereof |
| 03/24/2004 | CN1483421A Fracture reduciton ointment and preparation preocess thereof |
| 03/24/2004 | CN1142939C Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 03/24/2004 | CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/24/2004 | CN1142927C Chalcone coumarins |
| 03/24/2004 | CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use |